VERO insider trading
OTC Markets OTCPK HealthcareVenus Concept Inc.: insider trade history from SEC Form 4 filings.
About Venus Concept Inc.
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Company website: www.venus.ai
VERO insider activity at a glance
FilingIQ tracks 166 insider transactions for VERO in filings since Nov 7, 2019. The most recent transaction is dated Mar 26, 2026.
Across the full history, 33 open-market purchases
and 50 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VERO insider trades is 55.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest VERO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for VERO?
- FilingIQ tracks 166 Form 4 insider transactions for VERO (Venus Concept Inc.), covering filings from Nov 7, 2019 onwards. 0 of those are dated within the last 90 days.
- Are VERO insiders net buyers or net sellers?
- Across the full Form 4 history for VERO, 33 transactions (20%) were open-market purchases and 50 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VERO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is VERO in?
- Venus Concept Inc. (VERO) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $576328.
Methodology & sources
Every VERO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.